Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
16 Marzo 2023 - 2:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934.
Commission File Number 001-36310
Concert Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
65 Hayden Avenue, Suite 3000N
Lexington, Massachusetts 02421
(781) 860-0045
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.001 per share
Series X1 Preferred Stock, par value $0.001
per share
Pre-Funded Warrants to Purchase Shares of Common Stock, par value
$0.001 per share
Warrants to Purchase Shares of Series X1 Preferred
Stock, par value $0.001 per share
(Title of each class of securities covered by this
Form)
None
(Titles of all other classes of securities for
which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate
the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1) |
☒ |
|
|
|
|
|
Rule 12g-4(a)(2) |
☐ |
|
|
|
|
|
Rule 12h-3(b)(1)(i) |
☒ |
|
|
|
|
|
Rule 12h-3(b)(1)(ii) |
☐ |
|
|
|
|
|
Rule 15d-6 |
☐ |
|
|
|
|
|
Rule 15d-22(b) |
☐ |
|
|
|
|
Approximate number of holders of record as of
the certification or notice date: one (1).
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, Concert Pharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned
duly authorized person.
Date: |
March 16, 2023 |
|
CONCERT PHARMACEUTICALS, INC. |
|
|
|
|
|
|
|
|
By: |
/s/ Erik Zwicker |
|
|
|
Name: |
Erik Zwicker |
|
|
|
Title: |
Secretary |
Grafico Azioni Concert Pharmaceuticals (NASDAQ:CNCE)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Concert Pharmaceuticals (NASDAQ:CNCE)
Storico
Da Set 2023 a Set 2024